Whole genome sequencing (WGS) has been associated with a significant reduction in Salmonella cases in Australia. Researchers ...

Genedx Holding Corp. launched Genomedx Prenatal, its whole genome sequencing test, to provide more definitive diagnoses of the causes of fetal abnormalities identified by ultrasound. By combining the ...

It’s Tuesday, Jan. 6, 2026, and today’s FSN Daily shifts from big-picture outlooks to the systems and science shaping food safety right now. We’re tracking how new tools like whole genome sequencing ...

Bioinformatics is rapidly changing the course of human health and history. Scientists and researchers use data like never before to save countless lives each day. Bioinformatics fuels new discoveries ...

The projected fair value for GeneDx Holdings is US$253 based on 2 Stage Free Cash Flow to Equity GeneDx Holdings' US$152 share price signals that it might be 40% undervalued The US$165 analyst price ...

A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.

This story is part of the KXAN Data Hub, where numbers help tell the whole story. We’ve created several data-driven stories and databases on topics including weather and climate, politics, education, ...

Plant physiological ecology has increasingly recognized volatile organic compounds (VOCs) as integral mediators of plant ...

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and ...

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic ...